216 related articles for article (PubMed ID: 17303473)
61. Telmisartan: the ACE of ARBs?
Sharma AM
Hypertension; 2006 May; 47(5):822-3. PubMed ID: 16567592
[No Abstract] [Full Text] [Related]
62. Blockade of atrial angiotensin II type 1 receptors: a novel antiarrhythmic strategy to prevent atrial fibrillation?
Klein HU; Goette A
J Am Coll Cardiol; 2003 Jun; 41(12):2205-6. PubMed ID: 12821248
[No Abstract] [Full Text] [Related]
63. Potential effect of angiotensin II receptor blockade in adipose tissue and bone.
Nakagami H; Osako MK; Morishita R
Curr Pharm Des; 2013; 19(17):3049-53. PubMed ID: 23176218
[TBL] [Abstract][Full Text] [Related]
64. Epigenetic control of podocyte differentiation: a new target of the renin-angiotensin system in kidney disease.
Feliers D
Kidney Int; 2015 Oct; 88(4):668-70. PubMed ID: 26422623
[TBL] [Abstract][Full Text] [Related]
65. Comparison of 3D structures and AT(1) binding properties of pyrazolidine-3,5-diones and tetrahydropyridazine-3,6-diones with parent antihypertensive drug irbesartan.
Le Bourdonnec B; Cauvin C; Meulon E; Yous S; Goossens JF; Durant F; Houssin R; Hénichart JP
J Med Chem; 2002 Oct; 45(21):4794-8. PubMed ID: 12361407
[TBL] [Abstract][Full Text] [Related]
66. Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia.
Nonn O; Fischer C; Geisberger S; El-Heliebi A; Kroneis T; Forstner D; Desoye G; Staff AC; Sugulle M; Dechend R; Pecks U; Kollmann M; Stern C; Cartwright JE; Whitley GS; Thilaganathan B; Wadsack C; Huppertz B; Herse F; Gauster M
Hypertension; 2021 May; 77(5):1723-1736. PubMed ID: 33775117
[TBL] [Abstract][Full Text] [Related]
67. Binding characteristics of [(3)H]-irbesartan to human recombinant angiotensin type 1 receptors.
Vanderheyden PM; Verheijen I; Fierens FL; Backer JP; Vauquelin G
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):159-65. PubMed ID: 11967808
[TBL] [Abstract][Full Text] [Related]
68. Commentary for Clancy, P et al., ARBs and ERK activation: new insights on human atherosclerosis.
Thatcher S
Atherosclerosis; 2014 Sep; 236(1):131-2. PubMed ID: 25036239
[No Abstract] [Full Text] [Related]
69. Let's be certain about sartans (and other potential new therapies for CNS injury).
Moon L
Brain; 2015 Nov; 138(Pt 11):3136-9. PubMed ID: 26503939
[No Abstract] [Full Text] [Related]
70. Evaluation of γ-cyclodextrin effect on permeation of lipophilic drugs: application of cellophane/fused octanol membrane.
Muankaew C; Jansook P; Loftsson T
Pharm Dev Technol; 2017 Jun; 22(4):562-570. PubMed ID: 27146583
[TBL] [Abstract][Full Text] [Related]
71. Renin-angiotensin system blockade: therapeutic implications beyond blood pressure control.
Kaplan NM
J Clin Hypertens (Greenwich); 2007 Nov; 9(11 Suppl 4):2-3. PubMed ID: 18080358
[No Abstract] [Full Text] [Related]
72. Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems.
Ernsberger P; Koletsky RJ
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jul; 373(4):245-58. PubMed ID: 16783586
[TBL] [Abstract][Full Text] [Related]
73. Pharmacokinetic and pharmacodynamic of irbesartan in renal hypertensive dogs under non-steady-state and steady-state conditions.
Huang XH; Qiu FR; Xie HT; Li J
Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):121-6. PubMed ID: 16010871
[TBL] [Abstract][Full Text] [Related]
74. Tetrazolone as an acid bioisostere: application to marketed drugs containing a carboxylic acid.
Duncton MA; Murray RB; Park G; Singh R
Org Biomol Chem; 2016 Oct; 14(39):9343-9347. PubMed ID: 27714239
[TBL] [Abstract][Full Text] [Related]
75. The renin-angiotensin system: new horizons.
Denton KM
J Hypertens; 2011 Oct; 29(10):1857-8. PubMed ID: 21904152
[No Abstract] [Full Text] [Related]
76. [Role of angiotensin II receptor antagonists in the treatment of metabolic syndrome].
Botella Carretero JI; Fresneda Moreno J; Manzano Espinosa L
Rev Clin Esp; 2006 Jun; 206(6):284-8. PubMed ID: 16762293
[TBL] [Abstract][Full Text] [Related]
77. Angiotensin receptor blockers and drug-drug interactions.
Sica DA
Expert Opin Drug Saf; 2005 Jan; 4(1):139-40. PubMed ID: 15709904
[TBL] [Abstract][Full Text] [Related]
78. Clinical pharmacology of the angiotensin receptor antagonists.
Sica DA
J Clin Hypertens (Greenwich); 2001; 3(1):45-9. PubMed ID: 11416682
[No Abstract] [Full Text] [Related]
79. Angiotensin receptor antagonists--a new class of antihypertensive drug.
Gibbs CR; Ferner RE; Beevers DG
J Clin Pharm Ther; 1996 Jun; 21(3):127-30. PubMed ID: 8873843
[No Abstract] [Full Text] [Related]
80. Use of Angiotensin Receptor Blockers and Risk of Alzheimer's Disease: A Class Effect?
Mangoni AA; Jarmuzewska EA
Curr Rev Clin Exp Pharmacol; 2021; 16(1):2-3. PubMed ID: 34528501
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
